The impact of obstructive sleep apnea on nonalcoholic fatty liver disease.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing disease associations and mechanistic pathways without a systematic review protocol or meta-analysis
PubMed 37850091 · doi:10.3389/fendo.2023.1254459
What was done
This was a narrative review synthesizing literature retrieved from PubMed and Medline on the relationship between obstructive sleep apnea (OSA) and nonalcoholic fatty liver disease (NAFLD), focusing on clinical associations and underlying biological mechanisms.
What was found
The abstract reports no numerical findings, effect sizes, or study counts. It qualitatively notes that OSA is closely associated with NAFLD and impacts its progression, while highlighting a current lack of sufficient high-quality clinical studies to confirm a causal or concomitant relationship.
Why it matters
Clarifying the mechanistic links between sleep apnea-induced hypoxia and liver pathology may aid in identifying preventive measures and therapeutic targets for NAFLD.
Limits
The review is narrative rather than systematic, with no quantitative synthesis, formal study quality assessment, or reported search methodology. The abstract specifically notes an absence of high-quality clinical trials establishing causality.
Cited by
- supports Untreated sleep apnea can cause damage and dysfunction in the liver, kidneys, brain, heart, and immune system.